- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.01. | Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics | ||
| 07.01. | New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO | ||
| 07.01. | Verona touts 'exceptionally strong' launch of blockbuster hopeful COPD treatment Ohtuvayre | ||
| 07.01. | Wegovy and Zepbound tipped to fuel $20B boom in heart failure market | ||
| 07.01. | After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter | ||
| 07.01. | Bausch + Lomb re-ups 'Faces of Glaucoma' campaign to raise awareness of the eye disease | ||
| 06.01. | Klick Health swoops in to acquire life sci market access agency Peregrine | ||
| 06.01. | FDA warning letter reveals quality control, data integrity issues at Viatris plant in India | ||
| 06.01. | FDA looks to clarify confirmatory trial mandate for accelerated approvals | ||
| 06.01. | Pfizer, PhRMA rank among groups pledging funding for Trump's inauguration: NYT | ||
| 06.01. | In €500M deal, Merck buys Ireland vaccines plant from CDMO WuXi Biologics | ||
| 06.01. | Citius Oncology weighs strategic options on road to launching newly-approved lymphoma med | ||
| 06.01. | 'Ozempic's biggest night': GLP-1s back in Hollywood spotlight at Lilly-backed 2025 Golden Globes | ||
| 06.01. | Amylyx names chief commercial officer as GLP-1 receptor antagonist launch plans start ramping up | ||
| 03.01. | Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row | ||
| 03.01. | Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate | ||
| 03.01. | BioNTech inks settlements with NIH, Penn in COVID-19 vaccine royalty disputes | ||
| 03.01. | CRO Veeda unveils 'modern and dynamic' rebrand to mirror expansion into CDMO services | ||
| 03.01. | Astellas, Endo issue US drug recalls over empty capsule, ingredient concerns | ||
| 03.01. | Study sparks call for funding reforms to protect patient groups from pharma influence | ||
| 02.01. | Regulatory tracker: Amgen's bispecific approved for small cell lung cancer in UK | ||
| 02.01. | Digital Health Trends 2024: Implications for Research and Patient Care | ||
| 02.01. | Fierce Pharma Asia-Roche, Innovent's ADC deal; Lessons from AstraZeneca's China probes; Viatris' warning letter | ||
| 02.01. | Lilly looks to 'protect its interests' by moving to join FDA lawsuit over compounded tirzepatide | ||
| 02.01. | Currax's first Contrave TV ad claims 'Cravings Don't Own Me' complete with classic song parody |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
